Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 271,300 | 155,580 | 58,940 | 266,870 | 217,800 |
| Depreciation Amortization | 12,400 | 8,340 | 4,230 | 17,760 | 13,490 |
| Other Working Capital | -3,700 | -1,670 | 5,190 | -36,950 | -58,300 |
| Other Operating Activity | -6,290 | -2,570 | -3,950 | 970 | 100 |
| Operating Cash Flow | $273,710 | $159,680 | $64,410 | $248,650 | $173,090 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,640 | -6,740 | -3,890 | -9,460 | -6,180 |
| Other Investing Activity | -78,680 | -38,630 | -20,330 | -234,470 | -124,120 |
| Investing Cash Flow | $-95,320 | $-45,370 | $-24,220 | $-243,930 | $-130,300 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -203,370 | 390 | 120 | -3,320 | -4,670 |
| Financing Cash Flow | $-203,370 | $390 | $120 | $-3,320 | $-4,670 |
| Exchange Rate Effect | -4,840 | 113,320 | -4,030 | -2,370 | 610 |
| Beginning Cash Position | 237,280 | 237,280 | 237,280 | 238,260 | 238,260 |
| End Cash Position | 207,450 | 350,610 | 273,550 | 237,280 | 276,990 |
| Net Cash Flow | $-29,820 | $113,320 | $36,270 | $-980 | $38,720 |
| Free Cash Flow | |||||
| Operating Cash Flow | 273,710 | 159,680 | 64,410 | 248,650 | 173,090 |
| Free Cash Flow | 273,710 | 159,680 | 64,410 | 248,650 | 173,090 |